Clopidogrel and vascular disease prevention

Stella S. Daskalopoulou Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital, Royal Free and University College Medical School, London, UK

Gerard Stansby Northern Vascular Unit and University Department of Surgery, Newcastle upon Tyne, UK

Dimitri P. Mikhailidis Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital, Royal Free and University College Medical School, London, UKCorrespondenceemail: [email protected]

SUMMARY

In this editorial we consider some aspects of the use of clopidogrel in current clinical practice.

Clopidogrel may be especially effective in patients with peripheral arterial disease. However, this impression requires confirmation in appropriately designed trials.

Clopidogrel is a useful, evidence-based, antiplatelet agent.

Key words: :

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clopidogrel and vascular disease prevention

Information for

Open access

Opportunities

Help and information

Clopidogrel and vascular disease prevention

SUMMARY

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature